Apollo Hospitals Enterprises has suffered heavy setback during the first quarter ended June 2017 and its standalone net profit declined by 51.2 per cent to Rs.35.21 crore from Rs.72.17 crore in the corresponding period of last year due to the loss of Rs.14.5 crore incurred at Navi Mumbai hospital and increase in marketing expenses, doctor and allied staff recruitment costs of new and existing hospitals. The Government regulation on stent have also impacted bottom line. However, its revenue increased by 14.9 per cent to Rs.1,684 crore from Rs.1,465 crore basically due to strong growth in pharmacy segment. With lower net profit, EPS declined to Rs.2.53 from Rs.5.19 in the last period.
Income from healthcare segment increased by 10.4 per cent to Rs.920 crore from Rs.833 crore and overall occupancy across the group was at 4,278 beds or 62 per cent. Its income from pharmacy segment moved up by 20.9 per cent to Rs.764 crore from Rs.632 crore. The profit of healthcare services segment declined by 27.8 per cent to Rs.84.31 crore from Rs.116.76 crore. However, profit from pharmacy segment went up sharply by 59.6 per cent to Rs.24.68 crore from Rs.15.46 crore. The pharmacy segment added 87 stores in Q1 and its Pan-India network now reached at 2,643 stores.
Apollo Hospitals has launched first integrated hospital in Guwahati and now set to offer comprehensive oncology services in Navi Mumbai in the current year. It is also expanding Apollo Cancer Institutes into more centres.
Dr Prathap Reddy, chairman, said, “Creation of health infrastructure is a top priority which the entire industry must pursue on a war footing. We have aggressively added capacity while leveraging technology and new formats to amplify reach and productivity of existing centres. With over 2,400 new beds added in the last 3 years, we continue to have a pre-eminent position in the hospital landscape in the country and now have clear plans to further augment our clinical offerings in specialties like oncology, neurosciences, orthopaedics and transplants”.
Its consolidated revenues improved by 14 per cent during the first quarter ended June 2017 to Rs.1,903 crore from Rs.1,664 crore in the similar quarter of last year. However its net profit declined sharply to Rs.0.90 crore from Rs.48.8 crore and EPS worked out to Rs.0.07.
Apollo hospitals standalone
.png)
